Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Early endothelial progenitor cells and vascular stiffness in psoriasis and psoriatic arthritis.

Patschan D, Sugiarto N, Henze E, Mößner R, Mohr J, Müller GA, Patschan S.

Eur J Med Res. 2018 Nov 9;23(1):56. doi: 10.1186/s40001-018-0352-7.

2.

The weak voltage dependence of pannexin 1 channels can be tuned by N-terminal modifications.

Michalski K, Henze E, Nguyen P, Lynch P, Kawate T.

J Gen Physiol. 2018 Dec 3;150(12):1758-1768. doi: 10.1085/jgp.201711804. Epub 2018 Oct 30.

PMID:
30377218
3.

Dynamics of pulse wave velocity and vascular augmentation index in association with endothelial progenitor cells in SLE.

Korsten P, Patschan D, Henze E, Niewold TB, Müller GA, Patschan S.

Lupus Sci Med. 2016 Dec 23;3(1):e000185. doi: 10.1136/lupus-2016-000185. eCollection 2016.

4.

Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiation.

Patschan S, Tampe D, Müller C, Seitz C, Herink C, Müller GA, Zeisberg E, Zeisberg M, Henze E, Patschan D.

BMC Musculoskelet Disord. 2016 Aug 12;17:339. doi: 10.1186/s12891-016-1197-2.

5.

The endothelial-to-mesenchymal transition and endothelial cilia in EPC-mediated postischemic kidney protection.

Patschan D, Schwarze K, Henze E, Patschan S, Müller GA.

Am J Physiol Renal Physiol. 2016 Apr 1;310(7):F679-F687. doi: 10.1152/ajprenal.00306.2015. Epub 2016 Jan 20.

6.

Endothelial autophagy and Endothelial-to-Mesenchymal Transition (EndoMT) in eEPC treatment of ischemic AKI.

Patschan D, Schwarze K, Henze E, Patschan S, Müller GA.

J Nephrol. 2016 Oct;29(5):637-44. doi: 10.1007/s40620-015-0222-0. Epub 2015 Aug 20.

7.

Tocilizumab increases EPC regeneration in rheumatoid arthritis.

Patschan S, Nemirovsky K, Henze E, Scholze J, Müller GA, Patschan D.

Scand J Rheumatol. 2014;43(6):528-30. doi: 10.3109/03009742.2014.926985. Epub 2014 Sep 15. No abstract available.

PMID:
25222920
8.

eEOC-mediated modulation of endothelial autophagy, senescence, and EnMT in murine diabetic nephropathy.

Patschan D, Schwarze K, Henze E, Becker JU, Patschan S, Müller GA.

Am J Physiol Renal Physiol. 2014 Sep 15;307(6):F686-94. doi: 10.1152/ajprenal.00650.2013. Epub 2014 Jul 30.

9.

Fibrate treatment of eEOCs in murine AKI.

Patschan D, Schwarze K, Henze E, Patschan S, Scheidemann R, Müller GA.

J Nephrol. 2014 Feb;27(1):37-44. doi: 10.1007/s40620-013-0027-y. Epub 2014 Jan 16.

PMID:
24430761
10.

Angiopoietin-1 treated early endothelial outgrowth cells (eEOCs) are activated in vitro and reduce renal damage in murine acute ischemic kidney injury (iAKI).

Patschan D, Rinneburger J, Idrizi N, Backhaus R, Schwarze K, Henze E, Patschan S, Müller GA.

BMC Nephrol. 2013 Oct 21;14:227. doi: 10.1186/1471-2369-14-227.

11.

Endothelial progenitor cells in systemic lupus erythematosus.

Patschan S, Patschan D, Potulski M, Henze E, Scholze J, Müller GA.

J Nephrol. 2013 Nov-Dec;26(6):1065-72. doi: 10.5301/jn.5000273. Epub 2013 Jul 11.

PMID:
24052468
12.

Bone morphogenetic protein-5 and early endothelial outgrowth cells (eEOCs) in acute ischemic kidney injury (AKI) and 5/6-chronic kidney disease.

Patschan D, Schwarze K, Lange A, Meise N, Henze E, Becker JU, Patschan S, Müller GA.

Am J Physiol Renal Physiol. 2013 Aug 1;305(3):F314-22. doi: 10.1152/ajprenal.00677.2012. Epub 2013 May 15. Erratum in: Am J Physiol Renal Physiol. 2013 Dec 15;305(12):F1813.

13.

Angiopoietin-2 modulates eEOC-mediated renoprotection in AKI in a dose-dependent manner.

Patschan D, Backhaus R, Elle HJ, Schwarze K, Henze E, Becker JU, Patschan S, Müller GA.

J Nephrol. 2013 Jul-Aug;26(4):667-74. doi: 10.5301/jn.5000255. Epub 2013 Mar 6.

PMID:
23475469
14.

Impairment and Differential Expression of PR3 and MPO on Peripheral Myelomonocytic Cells with Endothelial Properties in Granulomatosis with Polyangiitis.

Patschan S, Patschan D, Henze E, Blaschke S, Wessels JT, Müller GA.

Int J Nephrol. 2012;2012:715049. doi: 10.1155/2012/715049. Epub 2012 Jun 26.

15.

The hormone melatonin stimulates renoprotective effects of "early outgrowth" endothelial progenitor cells in acute ischemic kidney injury.

Patschan D, Hildebrandt A, Rinneburger J, Wessels JT, Patschan S, Becker JU, Henze E, Krüger A, Müller GA.

Am J Physiol Renal Physiol. 2012 May 15;302(10):F1305-12. doi: 10.1152/ajprenal.00445.2011. Epub 2012 Feb 22.

16.

Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients.

Hutchinson JA, Riquelme P, Sawitzki B, Tomiuk S, Miqueu P, Zuhayra M, Oberg HH, Pascher A, Lützen U, Janssen U, Broichhausen C, Renders L, Thaiss F, Scheuermann E, Henze E, Volk HD, Chatenoud L, Lechler RI, Wood KJ, Kabelitz D, Schlitt HJ, Geissler EK, Fändrich F.

J Immunol. 2011 Sep 1;187(5):2072-8. doi: 10.4049/jimmunol.1100762. Epub 2011 Jul 29.

17.

Endothelial progenitor cells (EPC) in sepsis with acute renal dysfunction (ARD).

Patschan SA, Patschan D, Temme J, Korsten P, Wessels JT, Koziolek M, Henze E, Müller GA.

Crit Care. 2011;15(2):R94. doi: 10.1186/cc10100. Epub 2011 Mar 11.

18.

Activation of cerebral peroxisome proliferator-activated receptors γ (PPARγ) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat.

Zuhayra M, Zhao Y, von Forstner C, Henze E, Gohlke P, Culman J, Lützen U.

Neuropathol Appl Neurobiol. 2011 Dec;37(7):738-52. doi: 10.1111/j.1365-2990.2011.01169.x.

PMID:
21366664
19.

Expression of L amino acid transport system 1 and analysis of iodine-123-methyltyrosine tumor uptake in a pancreatic xenotransplantation model using fused high-resolution-micro-SPECT-MRI.

von Forstner C, Zuhayra M, Ammerpohl O, Zhao Y, Tiwari S, Jansen O, Kalthoff H, Henze E, Egberts JH.

Hepatobiliary Pancreat Dis Int. 2011 Feb;10(1):30-7.

PMID:
21269932
20.

Imaging of acute heart-transplant rejection using 99m-Technetium labelled oligonucleotides against interleukin-2 mRNA in rats.

Gierthmuehlen M, Sommer P, Zuhayra M, Hedderich J, Jaenig U, Faendrich F, Henze E, Kampen WU.

Eur J Cardiothorac Surg. 2010 May;37(5):1111-6. doi: 10.1016/j.ejcts.2009.12.014. Epub 2010 Jan 29.

PMID:
20116274
21.

Epac-1 activator 8-O-cAMP augments renoprotective effects of syngeneic [corrected] murine EPCs in acute ischemic kidney injury.

Patschan D, Patschan S, Wessels JT, Becker JU, David S, Henze E, Goligorsky MS, Müller GA.

Am J Physiol Renal Physiol. 2010 Jan;298(1):F78-85. doi: 10.1152/ajprenal.00485.2009. Epub 2009 Nov 11. Erratum in: Am J Physiol Renal Physiol. 2010 Aug;299(2):F467.

22.

New approach for the synthesis of [18F]fluoroethyltyrosine for cancer imaging: simple, fast, and high yielding automated synthesis.

Zuhayra M, Alfteimi A, Forstner CV, Lützen U, Meller B, Henze E.

Bioorg Med Chem. 2009 Nov 1;17(21):7441-8. doi: 10.1016/j.bmc.2009.09.029. Epub 2009 Sep 20.

PMID:
19804977
23.

LDL lipid apheresis rapidly increases peripheral endothelial progenitor cell competence.

Patschan D, Patschan S, Henze E, Wessels JT, Koziolek M, Müller GA.

J Clin Apher. 2009;24(5):180-5. doi: 10.1002/jca.20208.

PMID:
19753649
24.

Radiosynoviorthesis of the temporomandibular joint--initial clinical application.

Kampen WU, Czech N, von Forstner C, Henze E, Möller B, Bartsch MS.

Nuklearmedizin. 2009;48(5):N47-9. No abstract available.

PMID:
20512195
25.

C-H bond activation of coordinated pyridine: ortho-pyridyl-ditechnetiumhydridocarbonyl metal cyclus. Crystal structure and dynamic behavior in solution.

Zuhayra M, Lützen U, Lützen A, Papp L, Henze E, Friedrichs G, Oberdorfer F.

Inorg Chem. 2008 Nov 3;47(21):10177-82. doi: 10.1021/ic8015063. Epub 2008 Oct 10.

PMID:
18844344
26.

Simplified fast and high yielding automated synthesis of [18F]fluoroethylcholine for prostate cancer imaging.

Zuhayra M, Alfteimi A, Papp L, Lützen U, Lützen A, Von Forstner C, Meller B, Henze E.

Bioorg Med Chem. 2008 Oct 15;16(20):9121-6. doi: 10.1016/j.bmc.2008.09.031. Epub 2008 Sep 13.

PMID:
18819809
27.

Gene expression patterns and tumor uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an orthotopic mouse xenotransplantation model of pancreatic cancer.

von Forstner C, Egberts JH, Ammerpohl O, Niedzielska D, Buchert R, Mikecz P, Schumacher U, Peldschus K, Adam G, Pilarsky C, Grutzmann R, Kalthoff H, Henze E, Brenner W.

J Nucl Med. 2008 Aug;49(8):1362-70. doi: 10.2967/jnumed.107.050021. Epub 2008 Jul 16.

28.

[Extended sentinel lymph node dissection in radical prostatectomy for prostate cancer: a study in the Kiel risk population].

Hautmann S, Beitz S, Naumann M, Lützen U, Seif C, Stübinger SH, van der Horst C, Braun PM, Leuschner I, Henze E, Jünemann KP.

Urologe A. 2008 Mar;47(3):299-303. doi: 10.1007/s00120-008-1652-2. German.

PMID:
18273596
29.

Serious complications after radiosynoviorthesis. Survey on frequency and treatment modalities.

Kampen WU, Matis E, Czech N, Soti Z, Gratz S, Henze E.

Nuklearmedizin. 2006;45(6):262-8.

PMID:
17149495
30.

A planar water tetramer with tetrahedrally coordinated water embedded in a hydrogen bonding network of [Tc4(CO)12-(mu3-OH)4.4H2O].

Zuhayra M, Kampen WU, Henze E, Soti Z, Zsolnai L, Huttner G, Oberdorfer F.

J Am Chem Soc. 2006 Jan 18;128(2):424-5.

PMID:
16402825
31.

Peroxide release into saliva from five different home bleaching systems in vivo.

Hannig C, Zech R, Henze E, Dreier S, Attin T.

Am J Dent. 2005 Feb;18(1):13-8.

PMID:
15810475
32.

Clinical efficacy of radiation synovectomy in digital joint osteoarthritis.

Kampen WU, Hellweg L, Massoudi-Nickel S, Czech N, Brenner W, Henze E.

Eur J Nucl Med Mol Imaging. 2005 May;32(5):575-80. Epub 2004 Dec 14.

PMID:
15599524
33.

[Uncomplicated pregnancy and birth of a normal child in thyroid cancer after high-dose 68 Gbq iodine 131].

Massoudi-Nickel S, Kampen WU, Henze E, Knapp WH, Hornik S.

Nuklearmedizin. 2004 Oct;43(5):N68-70. No abstract available.

PMID:
15536693
34.
35.

Immobilisation and activity of human alpha-amylase in the acquired enamel pellicle.

Hannig C, Attin T, Hannig M, Henze E, Brinkmann K, Zech R.

Arch Oral Biol. 2004 Jun;49(6):469-75.

PMID:
15099804
36.

111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model.

Brenner W, Aicher A, Eckey T, Massoudi S, Zuhayra M, Koehl U, Heeschen C, Kampen WU, Zeiher AM, Dimmeler S, Henze E.

J Nucl Med. 2004 Mar;45(3):512-8.

37.

CT-guided lymphoscintigraphy in patients with squamous cell carcinoma of the head and neck: a feasibility study.

Muhle C, Brenner W, Südmeyer M, Höft S, Galalae R, Czech N, Biederer J, Ahn JM, Maune S, Henze E.

Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):940-4. Epub 2004 Feb 25.

PMID:
14985867
38.

Myeloprotective effects of different amifostine regimens in rabbits undergoing high-dose treatment with 186rhenium-(tin)1,1- hydroxyethylidene diphosphonate (186Re-HEDP).

Brenner W, Kampen WU, Brümmer C, Von Forstner C, Zuhayra M, Muhle C, Czech N, Henze E.

Cancer Biother Radiopharm. 2003 Dec;18(6):887-93.

PMID:
14969601
39.

[Radiosynovectomy. Nuclear medical treatment for inflammatory rheumatic joint diseases].

Kampen WU, Czech N, Massoudi S, Zuhayra M, Brenner W, Henze E.

Med Monatsschr Pharm. 2003 Sep;26(9):303-8. Review. German. No abstract available.

PMID:
14526614
40.

Determination of peroxides in saliva--kinetics of peroxide release into saliva during home-bleaching with Whitestrips and Vivastyle.

Hannig C, Zech R, Henze E, Dorr-Tolui R, Attin T.

Arch Oral Biol. 2003 Aug;48(8):559-66.

PMID:
12828984
41.

Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling.

Aicher A, Brenner W, Zuhayra M, Badorff C, Massoudi S, Assmus B, Eckey T, Henze E, Zeiher AM, Dimmeler S.

Circulation. 2003 Apr 29;107(16):2134-9. Epub 2003 Apr 14.

PMID:
12695305
42.

Radio-tympano-sinu-orthesis with 186Re-colloid: a new treatment modality for chronic otitis media and paranasal mucositis.

Kampen WU, Godbersen GS, Czech N, Besch OF, Brenner W, Henze E.

J Nucl Med. 2003 Apr;44(4):559-64.

43.

Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.

Brenner W, Kampen WU, Brümmer C, von Forstner C, Zuhayra M, Czech N, Muhle C, Henze E.

J Nucl Med. 2003 Feb;44(2):247-51.

44.

High-dose treatment with (186)Re-HEDP or (153)Sm-EDTMP combined with amifostine in a rabbit model.

Brenner W, Kampen WU, von Forstner C, Brümmer C, Zuhayra M, Muhle C, Czech N, Henze E.

J Nucl Med. 2001 Oct;42(10):1545-50.

45.

Molecular biologic and scintigraphic analyses of somatostatin receptor-negative meningiomas.

Meewes C, Bohuslavizki KH, Krisch B, Held-Feindt J, Henze E, Clausen M.

J Nucl Med. 2001 Sep;42(9):1338-45.

47.

[Bone scintigraphy in the control of bone metastasis of breast cancer during pamidronate and tamoxifen combination therapy].

Massoudi S, Brenner W, Czech N, Kampen WU, Henze E.

Nuklearmedizin. 2001 Apr;40(2):N10-2. German. No abstract available.

PMID:
11354989
48.

Comparative study on the clinical use of protein S-100B and MIA (melanoma inhibitory activity) in melanoma patients.

Schmitz C, Brenner W, Henze E, Christophers E, Hauschild A.

Anticancer Res. 2000 Nov-Dec;20(6D):5059-63.

PMID:
11326668
49.

Long-term results of radiation synovectomy: a clinical follow-up study.

Kampen WU, Brenner W, Kroeger S, Sawula JA, Bohuslavizki KH, Henze E.

Nucl Med Commun. 2001 Feb;22(2):239-46.

PMID:
11258412
50.

[Use of radiosynoviorthesis in inflammatory rheumatic joint diseases].

Kampen WU, Brenner W, Czech N, Henze E.

Dtsch Med Wochenschr. 2001 Feb 23;126(8):210-2. German. No abstract available.

PMID:
11256026

Supplemental Content

Support Center